TNNI3 and plasma cell myeloma: As shown in Table 4, the results of multivariate logistic regression analyses revealed that T3 cTnI, T3 Pro-BNP, T2 LAVmin, T3 LAVmin, T2 LAVprep, and T3 LAVprep are independent risk factors for predicting cardiotoxicity in patients with multiple myeloma undergoing anthracycline chemotherapy.